At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction

World Psychiatry

Volumn 14, Issue 3, 2015, Pages 322-332

  Fusar Poli, Paolo ^a,b   Cappucciati, Marco ^a   Rutigliano, Grazia ^a   Schultze Lutter, Frauke ^c   Bonoldi, Ilaria ^a   Borgwardt, Stefan ^d   Riecher Rössler, Anita ^d   Addington, Jean ^e   Perkins, Diana ^f   Woods, Scott W ^g   McGlashan, Thomas H ^g   Lee, Jimmy ^h   Klosterkötter, Joachim ⁱ   Yung, Alison R ^j   McGuire, Philip ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h INSTITUTE OF MENTAL HEALTH   (Singapore)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

high risk services; prevention; prognostic accuracy; psychometric interviews; Psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL HIGH RISK INTERVIEW; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HIGH RISK PATIENT; HUMAN; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMETRY; PSYCHOSIS; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 84942526356     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20250     Document Type: Article

References (89)

1. Insel TR., Rethinking schizophrenia. Nature 2010; 468: 187-93.
2. McGorry PD., Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry. Biol Psychiatry 2013; 74: 394-5.
3. Arbyn M, Verdoodt F, Snijders P, et al., Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-83.
4. Michel C, Schultze-Lutter F, Schimmelmann BG., Screening instruments in child and adolescent psychiatry: general and methodological considerations. Eur Child Adolesc Psychiatry 2014; 23: 725-7.
5. Tabak AG, Herder C, Rathmann W, et al., Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-90.
6. Kapur S, Phillips AG, Insel TR., Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 2012; 17: 1174-9.
7. Fusar-Poli P, Borgwardt S, Bechdolf A, et al., The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013; 70: 107-20.
8. Yung AR, Phillips LJ, Yuen HP, et al,. Comprehensive Assessment of at Risk Mental State. Parkville: PACE Clinic, ORYGEN Research Centre, University of Melbourne, 2006.
9. Yung AR, Yuen HP, McGorry PD, et al., Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Zeal J Psychiatry 2005; 39: 964-71.
10. McGlashan T, Walsh B, Woods S., The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford: Oxford University Press, 2010.
11. Riecher-Rössler A, Aston J, Ventura J, et al., The Basel screening instrument for psychosis (BSIP): development, structure, reliability and validity. Fortschr Neurol Psychiatr 2008; 76: 207-16.
12. Yung AR, Stanford C, Cosgrave E, et al., Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006; 84: 57-66.
13. Klosterkotter J, Gross G, Huber G, et al., Evaluation of the Bonn Scale for the Assessment of Basic Symptoms-BSABS as an instrument for the assessment of schizophrenia proneness: a review of recent findings. Neurol Psychiatry Brain Res 1997; 5: 137-50.
14. Schultze-Lutter F, Addington J, Ruhrmann S, et al., Schizophrenia Proneness Instrument, Adult version (SPI-A). Rome: Fioriti, 2007.
15. Schultze-Lutter F, Koch E., Schizophrenia Proneness Instrument, Child and Youth version (SPI-CY). Rome: Fioriti, 2010.
16. Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, et al., Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des 2012; 18: 351-7.
17. Schultze-Lutter F., Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009; 35: 5-8.
18. Miller TJ, McGlashan TH, Rosen JL, et al., Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-15.
19. Schultze-Lutter F, Klosterkötter J, Picker H, et al., Predicting first-onset of psychosis by basic symptom criteria. Clin Neuropsychiatry 2007; 4: 11-22.
20. Woods SW, Addington J, Cadenhead KS, et al., Validity of the prodromal risk syndrome for psychosis: findings from North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894-908.
21. Fusar-Poli P, Bonoldi I, Yung AR, et al., Predicting psychosis: a meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 1-10.
22. Schultze-Lutter F, Michel C, Schmidt SJ, et al., EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 2015; 30: 405-16.
23. Fusar Poli P, Carpenter W, Woods SW, et al., Attenuated psychosis syndrome: ready for DSM-5.1? Annu Rev Clin Psychol 2014; 10: 155-92.
24. Schultze-Lutter F, Michel C, Ruhrmann S, et al., Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) Study. Schizophr Bull 2014; 40: 1499-08.
25. Kelleher I, Murtagh A, Molloy C, et al., Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. Schizophr Bull 2012; 38: 239-46.
26. Schimmelmann B, Michel C, Martz-Irngartinger A, et al., Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: findings from the BEAR and BEARS-Kid studies. World Psychiatry 2015; 14: 189-97.
27. Lindgren M, Manninen M, Kalska H, et al., Predicting psychosis in a general adolescent psychiatric sample. Schizophr Res 2014; 158: 1-6.
28. Manninen M, Lindgren M, Therman S, et al., Clinical high-risk state does not predict later psychosis in a delinquent adolescent population. Early Interv Psychiatry 2014; 8: 87-90.
29. Stroup DF, Berlin JA, Morton SC, et al., Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
30. Moher D, Liberati A, Tetzlaff J, et al., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
31. Whiting P, Rutjes AW, Reitsma JB, et al., The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
32. Macaskill P, Gatsonis C, Deeks J, et al., Cochrane handbook for systematic reviews of diagnostic test accuracy Version 1.0. In: Deeks JJ, Bossuyt PM, Gatsonis C (eds) The Cochrane Collaboration, 2010.
33. Smetana GW, Umscheid CA, Chang S, et al., Methods guide for authors of systematic reviews of medical tests: a collaboration between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine. In:, Chang SM, Matchar DB, Smetana GW, et al (eds). Methods guide for medical test reviews. Rockville: Agency for Healthcare Research and Quality, 2012.
34. Dwamena BA., MIDAS: computational and graphical routines for meta-analytical integration of diagnostic accuracy studies in Stata. Ann Arbor: Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School, 2007.
35. Harbord R, Whiting P., Meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009; 9: 211-29.
36. Janda S, Shahidi N, Gin K, et al., Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 2011; 97: 612-22.
37. Lipsey M, Wilson D., Practical meta-analysis. Thousand Oaks: Sage Publications, 2000.
38. Bekkar M, Djemaa H, Alitouche T., Evaluation measures for models assessment over imbalanced data sets. J Inf Eng Appl 2013; 3: 27-38.
39. Higgins JP, Thompson SG, Deeks JJ, et al., Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
40. Deeks JJ, Macaskill P, Irwig L., The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882-93.
41. Wanders LK, East JE, Uitentuis SE, et al., Diagnostic performance of narrowed spectrum endoscopy, autofluorescence imaging, and confocal laser endomicroscopy for optical diagnosis of colonic polyps: a meta-analysis. Lancet Oncol 2013; 14: 1337-47.
42. Li J, Fine J, Safdar N., Prevalence-dependent diagnostic accuracy measures. Stat Med 2007; 26: 3258-73.
43. Fagan TJ., Letter: Nomogram for Bayes theorem. N Engl J Med 1975; 293: 257.
44. Lee J, Rekhi G, Mitter N, et al., The Longitudinal Youth at Risk Study (LYRIKS)-an Asian UHR perspective. Schizophr Res 2013; 151: 279-83.
45. Yung AR, Nelson B, Stanford C, et al., Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008; 105: 10-17.
46. Schultze-Lutter F, Klosterkotter J, Ruhrmann S., Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res 2014; 154: 100-6.
47. Kotlicka-Antczak M, Pawelczyk T, Rabe-Jablonska J, et al., PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at-risk mental state. Early Interv Psychiatry (in press).
48. Addington J, Piskulic D, Perkins DO, et al., Affect recognition in people at clinical high risk of psychosis. Schizophr Res 2012; 140: 87-92.
49. Liu CC, Lai MC, Liu CM, et al., Follow-up of subjects with suspected pre-psychotic state in Taiwan. Schizophr Res 2011; 126: 65-70.
50. Simon AE, Gradel M, Cattapan-Ludewig K, et al., Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res 2012; 142: 108-15.
51. Spada G, Molteni S, Pistone C, et al., Identifying children and adolescents at ultra high risk for psychosis in Italian neuropsychiatry services: a feasibility study. Eur Child Adolesc Psychiatry (in press).
52. Klosterkötter J, Hellmich M, Steinmeyer EM, et al., Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64.
53. Perala J, Suvisaari J, Saarni SI, et al., Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19-28.
54. Morgan VA, McGrath JJ, Jablensky A, et al., Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med 2013; 23: 1-14.
55. Andreasson H, Nyman M, Krona H, et al., Predictors of length of stay in forensic psychiatry: the influence of perceived risk of violence. Int J Law Psychiatry 2014; 37: 635-42.
56. Hardoon S, Hayes JF, Blackburn R, et al., Recording of severe mental illness in United Kingdom primary care, 2000-2010. PLoS One 2013; 8: e82365.
57. Fazel S, Seewald K., Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry 2012; 200: 364-73.
58. Vesga-Lopez O, Blanco C, Keyes K, et al., Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65: 805-15.
59. Gothelf D, Schneider M, Green T, et al., Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry 2013; 52: 1192-203.
60. Johnstone EC, Ebmeier KP, Miller P, et al., Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005; 186: 18-25.
61. Di Forti M, Marconi A, Carra E, et al., Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry (in press).
62. Cowan DN, Weber NS, Fisher JA, et al., Incidence of adult onset schizophrenic disorders in the US military: patterns by sex, race and age. Schizophr Res 2011; 127: 235-40.
63. Qassem T, Bebbington P, Spiers N, et al., Prevalence of psychosis in black ethnic minorities in Britain: analysis based on three national surveys. Soc Psychiatry Psychiatr Epidemiol 2015; 50: 1057-64.
64. Llosa AE, Ghantous Z, Souza R, et al., Mental disorders, disability and treatment gap in a protracted refugee setting. Br J Psychiatry 2014; 204: 208-13.
65. Clancy MJ, Clarke MC, Connor DJ, et al., The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry 2014; 14: 75.
66. Hosmer W, Lemeshow S., Applied survival analysis: regression modeling of time to event data. New York: Wiley, 1999.
67. Mitchell AJ., Predicting the development of schizophrenia. Br J Psychiatry 2012; 200: 254.
68. Fusar-Poli P., Predicting the development of schizophrenia. Br J Psychiatry 2012; 200: 254-5.
69. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, et al., 'A rose is a rose is a rose', but at-risk criteria differ. Psychopathology 2013; 46: 75-87.
70. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization, 2006.
71. Thomas C, Hypponen E, Power C., Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006; 166: 682-88.
72. Mettlin C, Murphy GP, Babaian RJ, et al., The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1996; 77: 150-9.
73. Littrup PJ, Kane RA, Mettlin CJ, et al., Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1994; 74: 3146-58.
74. Shin A, Joo J, Yang HR, et al., Risk prediction model for colorectal cancer: National Health Insurance Corporation study, Korea. PLoS One 2014; 9: e88079.
75. Ghia D, Thomas P, Cordato D, et al., Low positive predictive value of the ABCD2 score in emergency department transient ischaemic attack diagnoses: the South Western Sydney Transient Ischaemic Attack Study. Int Med J 2012; 42: 913-8.
76. Giles MF, Rothwell PM., Systematic review and pooled analysis of published and unpublished validations of the ABCD and ABCD2 transient ischemic attack risk scores. Stroke 2010; 41: 667-73.
77. Sugamata W, Nakamura T, Uematsu M, et al., The combined assessment of flow-mediated dilation of the brachial artery and brachial-ankle pulse wave velocity improves the prediction of future coronary events in patients with chronic coronary artery disease. J Cardiol 2014; 64: 179-84.
78. Kim YA, Ku EJ, Khang AR, et al., Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes. Diabetes Res Clin Pract 2014; 106: 351-9.
79. Rozzini L, Vicini Chilovi B, Bertoletti E, et al., The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. J Geriatr Psychiatry Neurol 2008; 21: 261-7.
80. Chlebowski RT, Anderson GL, Lane DS, et al., Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 2007; 99: 1695-705.
81. Fusar-Poli P, Rocchetti M, Sardella A, et al., Disorder, not just a state of risk: meta-analysis of functioning and quality of life in subjects at high clinical risk for psychosis. Br J Psychiatry (in press).
82. Fusar-Poli P, Nelson B, Valmaggia L, et al., Comorbid depressive and anxiety disorders in 509 individuals with an at risk mental state: impact on psychopathology and transition to psychosis Schizophr Bull 2014; 40: 120-31.
83. Fusar-Poli P, Byrne M, Badger S, et al., Outreach and support in South London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at clinical high risk for psychosis. Eur Psychiatry 2012; 28: 315-26.
84. Yung AR, Woods SW, Ruhrmann S, et al., Whither the attenuated psychosis syndrome? Schizophr Bull 2012; 38: 1130-4.
85. Ruhrmann S, Schultze-Lutter F, Salokangas RK, et al., Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241-51.
86. Koutsouleris N, Riecher-Rössler A, Meisenzahl EM, et al., Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull 2015; 41: 471-82.
87. Fusar-Poli P, Yung AR, McGorry P, et al., Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med 2014; 44: 17-24.
88. Armando M, De Crescenzo F, Vicari S, et al., Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial. Early Interv Psychiatry (in press).
89. Kempton M, Bonoldi I, Valmaggia L, et al., Speed of psychosis progression in people at ultra high clinical risk: a complementary meta-analysis. JAMA Psychiatry 2015; 72: 622-3.